# Retrospective Evaluation of 5-FU Exposure Optimization in CRC Patients

> **NCT02055560** · — · COMPLETED · sponsor: **Saladax Biomedical, Inc.** · enrollment: 146 (actual)

## Conditions studied

- Metastatic Colorectal Cancer
- Adjuvant Colorectal Cancer
- 5-FU Containing Therapy Regimens

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02055560
- **Lead sponsor:** Saladax Biomedical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-04-02
- **Final completion:** 2015-12-18
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2022-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02055560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02055560, "Retrospective Evaluation of 5-FU Exposure Optimization in CRC Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02055560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*